Editorial on “Albumin-to-fibrinogen ratio as a prognostic biomarker to predict clinical outcome of non-small cell lung cancer individuals”

Takeshi Nagayasu, Takuro Miyazaki

doi:10.21037/jtd.2019.03.02

Editorial on “Albumin-to-fibrinogen ratio as a prognostic biomarker to predict clinical outcome of non-small cell lung cancer individuals”

DOI PubMed オープンアクセス

書誌事項

公開日: 2019-05-01

DOI

10.21037/jtd.2019.03.02

公開者: AME Publishing Company

この論文をさがす

CiNii Books

説明

As shown in “Albumin-to-fibrinogen ratio as a prognostic biomarker to predict clinical outcome of non-small cell lung cancer individuals”, by Li et al ., the albumin/fibrinogen ratio (AFR) is a valuable addition to the tools used to assess systemic inflammatory response (SIR) and/or nutrition status in patients with cancer and other serious diseases.